Economic burden and epidemiology of pneumonia in korean adults aged over 50 years

Journal of Korean Medical Science

Volumn 28, Issue 6, 2013, Pages 881-887

  Yoo, Kwang Ha ^a   Yoo, Chul Gyu ^b   Kim, Se Kyu ^c   Jung, Ji Ye ^c   Lee, Myung Goo ^d   Uh, Soo Taek ^e   Shim, Tae Sun ^f   Jeon, Kyeongman ^g   Shim, Jae Jeong ^h   Lee, Heung Bum ⁱ   Chung, Chi Ryang ⁱ   Kang, Kyung Woo ^j   Jung, Ki Suck ^k  

^a Konkuk University School of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Hallym University College of Medicine   (South Korea)

^e Soonchunhyang University College of Medicine   (South Korea)

^f University of Ulsan College of Medicine   (South Korea)

^g Samsung Medical Center   (South Korea)

^h Korea University College of Medicine   (South Korea)

ⁱ Chonbuk National University Medical School   (South Korea)

^j Sungkyunkwan University School of Medicine   (South Korea)

^k Hallym University   (South Korea)

more..

Author keywords

Adult; Cost of Illness; Korea; Pneumonia; Streptococcus pneumonia

Indexed keywords

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CLINICAL TRIAL; COMMUNITY-ACQUIRED INFECTIONS; ECONOMICS; FEMALE; HEALTH CARE COST; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; ISOLATION AND PURIFICATION; LENGTH OF STAY; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PNEUMONIA; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SOUTH KOREA; STREPTOCOCCUS PNEUMONIAE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HEALTH CARE COSTS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA; PNEUMONIA, PNEUMOCOCCAL; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE;

EID: 84891712841     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.6.888     Document Type: Article

References (27)

1. Mandell LA. Epidemiology and etiology of community-acquired pneumonia. Infect Dis Clin North Am 2004; 18: 761-76.
2. Korea National Statistical Office. 2010 annual report on the cause of death statistics: Nationwide. Daejeon: Korea National Statistical Office 2010.
3. Marrie TJ. Epidemiology of community-acquired pneumonia in the elderly. Semin Respir Infect 1990; 5: 260-8.
4. Riquelme R, Torres A, El-Ebiary M, de la Bellacasa JP, Estruch R, Mensa J, Fernández-Solá J, Hernández C, Rodriguez-Roisin R. Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med 1996; 154: 1450-5.
5. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA 1996; 275: 134-41.
6. Woo JH, Kang JM, Kim YS, Shin WS, Ryu JH, Choi JH, Kim YR, Cheong HJ, Uh ST, Park CS, et al. A prospective multicenter study of communityacquired pneumonia in adults with emphasis on bacterial etiology. Korean J Infect Dis 2001; 33: 1-7.
7. Van Mens SP, Meijvis SC, Endeman H, van Velzen-Blad H, Biesma DH, Grutters JC, Vlaminckx BJ, Rijkers GT. Longitudinal analysis of pneumococcal antibodies during community-acquired pneumonia reveals a much higher involvement of Streptococcus pneumoniae than estimated by conventional methods alone. Clin Vaccine Immunol 2011; 18: 796- 801.
8. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-54.
9. Lee HJ. Report on economic burden of pneumococcal diseases in Korea 2006. Daejeon: Korea Centers for Disease Control and Prevention, 2006.
10. Weycker D, Strutton D, Edelsberg J, Sato R, Jackson LA. Clinical and economic burden of pneumococcal disease in older US adults. Vaccine 2010; 28: 4955-60.
11. Sohn JW, Park SC, Choi YH, Woo HJ, Cho YK, Lee JS, Sim HS, Kim MJ. Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multi-center study. J Korean Med Sci 2006; 21: 602-7.
12. Yu CW, Park CW, Hwang BY, Song JY, Park O, Sohn JW, Cheong HJ, Kim WJ, Kim MJ, Park SC. Clinical features and prognosis of community-acquired pneumonia in the elderly patients. Korean J Infect Dis 2000; 32: 212-8.
13. Vogel F. Intravenous/oral sequential therapy in patients hospitalised with community-acquired pneumonia: which patients, when and what agents?Drugs 2002; 62: 309-17.
14. Dunbar LM, Wunderink RG, Habib MP, Smith LG, Tennenberg AM, Khashab MM, Wiesinger BA, Xiang JX, Zadeikis N, Kahn JB. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 2003; 37: 752-60.
15. Mandell LA. Epidemiology and etiology of community-acquired pneumonia. Infect Dis Clin North Am 2004; 18: 761-76.
16. World Health Organization. Pnumococcal disease. Available at http://www.who.int/entity/ith/diseases/pneumococcal/en [accessed on 10 June 2012].
17. Kyaw MH, Rose CE Jr, Fry AM, Singleton JA, Moore Z, Zell ER, Whitney CG; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis 2005; 192: 377-86.
18. Koivula I, Sten M, Mäkelä PH. Risk factors for pneumonia in the elderly. Am J Med 1994; 96: 313-20.
19. Song JH, Jung KS. Treatment guidelines for community-acquired pneumonia in Korea: an evidence-based approach to appropriate antimicrobial therapy. J Korean Med Assoc 2010; 53: 20-42.
20. World Health Organization. Immunization, vaccines and biologicals. Available at http://www.who.int/immunization/documents/positionpapers/en [accessed on 20 January 2011].
21. Kim KH. Pneumococcal polysaccharide vaccine, performance in local and effectiveness. Presentation at 34th Korean Otologic Society Symposium, 2007.
22. Choi E. Direct and indirect effects of pneumococcal protein conjugate vaccine. J Korean Med Assoc 2008; 51: 119-26.
23. Kang JH, Kim HB, Sohn JW, Lee SO, Chung MH, Cheong HJ, Choi YH, Choi JH, Choi JY, Choe HJ. Adult immunization schedule recommended by the Korean society of infectious diseases, 2007. Infect Chemother 2008; 40: 1-13.
24. Pneumonia. European lung white book. 2nd ed. Sheffield: European Respiratory Society/European Lung Foundation, 2003, p55-65.
25. Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults: infectious diseases society of America. Clin Infect Dis 2000; 31: 347-82.
26. Capelastegui A, Espana PP, Quintana JM, Areitio I, Gorordo I, Equrrola M, Bilbao A. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 2006; 27: 151-7.
27. Kim MJ. Disease burden of pneumococcal infection and serotypes of streptococcus pneumonia in Korean adults. Korea Centers for Disease Control and Prevention, 2007, p30-5.